GSK’s Advair, Serevent Add “Black Box” On Rare Asthma-Related Deaths

GlaxoSmithKline has revised labeling for Advair and Serevent to include "black box" warnings on an increased risk of asthma-related deaths in patients taking salmeterol

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet